Resolution, the grail for healthy ocular inflammation

Experimental Eye Research

Volumn 91, Issue 4, 2010, Pages 478-485

  Gronert, Karsten ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 PUFA; 15 lipoxygenase; Acute inflammation; Cornea; Heme oxygenase; Macrophage; Neuroprotection; Neutrophil; Resolution; Retina

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CORTICOSTEROID; DOCOSAHEXAENOIC ACID; HEME OXYGENASE; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT;

CHRONIC INFLAMMATION; CLINICAL FEATURE; ENZYME ACTIVITY; EYE INFLAMMATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; TISSUE REACTION; ANIMAL; ENDOPHTHALMITIS; EYE; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; PHYSIOLOGY;

ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; ENDOPHTHALMITIS; EYE; HEME OXYGENASE (DECYCLIZING); HUMANS; INFLAMMATION; MACROPHAGES; NEUTROPHILS;

EID: 78651469994     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.004     Document Type: Review

References (91)

1. Abraham N.G., da Silva J.L., Lavrovsky Y., Stoltz R.A., Kappas A., Dunn M.W., Schwartzman M.L. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest. Ophthalmol. Vis. Sci. 1995, 36:2202-2210.
2. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 2008, 60:79-127.
3. Aliberti J., Hieny S., Reis e Sousa C., Serhan C.N., Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 2002, 3:76-82.
4. Aliberti J., Serhan C., Sher A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 2002, 196:1253-1262.
5. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9:1390-1397.
6. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83:1467S-1476S.
7. Bach F.H. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J. 2005, 19:1216-1219.
8. Bannenberg G., Moussignac R.L., Gronert K., Devchand P.R., Schmidt B.A., Guilford W.J., Bauman J.G., Subramanyam B., Perez H.D., Parkinson J.F., Serhan C.N. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br. J. Pharmacol. 2004, 143:43-52.
9. Bazan N.G. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 2006, 29:263-271.
10. Bazan N.G. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J. Lipid. Res. 2009, 50(Suppl.):S400-S405.
11. Bellner L., Martinelli L., Halilovic A., Patil K., Puri N., Dunn M.W., Regan R.F., Schwartzman M.L. Heme oxygenase-2 deletion causes endothelial cell activation marked by oxidative stress, inflammation, and angiogenesis. J. Pharmacol. Exp. Ther. 2009, 331:925-932.
12. Biteman B., Hassan I.R., Walker E., Leedom A.J., Dunn M., Seta F., Laniado-Schwartzman M., Gronert K. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 2007, 21:2257-2266.
13. Bora N.S., Jha P., Bora P.S. The role of complement in ocular pathology. Semin Immunopathol. 2008, 30:85-95.
14. Calandria J.M., Marcheselli V.L., Mukherjee P.K., Uddin J., Winkler J.W., Petasis N.A., Bazan N.G. Selective survival rescue in 15-lipoxygenase-1 deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. J. Biol. Chem. 2009, 284:17877-17882.
15. Chang M.S., Schneider C., Roberts R.L., Shappell S.B., Haselton F.R., Boeglin W.E., Brash A.R. Detection and subcellular localization of two 15S-lipoxygenases in human cornea. Invest. Ophthalmol. Vis. Sci. 2005, 46:849-856.
16. Chiang N., Serhan C.N., Dahlen S.E., Drazen J.M., Hay D.W., Rovati G.E., Shimizu T., Yokomizo T., Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 2006, 58:463-487.
17. Connor K.M., SanGiovanni J.P., Lofqvist C., Aderman C.M., Chen J., Higuchi A., Hong S., Pravda E.A., Majchrzak S., Carper D., Hellstrom A., Kang J.X., Chew E.Y., Salem N., Serhan C.N., Smith L.E. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 2007, 13:868-873.
18. Cortina M.S., He J., Li N., Bazan N.G., Bazan H.E. Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest. Ophthalmol. Vis. Sci. 2010, 51:804-810.
19. Devchand P.R., Arita M., Hong S., Bannenberg G., Moussignac R.L., Gronert K., Serhan C.N. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 2003, 17:652-659.
20. Edwards A.O., Malek G. Molecular genetics of AMD and current animal models. Angiogenesis 2007, 10:119-132.
21. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
22. Gilroy D.W., Lawrence T., Perretti M., Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 2004, 3:401-416.
23. Gonzalez-Periz A., Planaguma A., Gronert K., Miquel R., Lopez-Parra M., Titos E., Horrillo R., Ferre N., Deulofeu R., Arroyo V., Rodes J., Claria J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 2006, 20:2537-2539.
24. Gonzalez-Periz A., Horrillo R., Ferre N., Gronert K., Dong B., Moran-Salvador E., Titos E., Martinez-Clemente M., Lopez-Parra M., Arroyo V., Claria J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009, 23:1946-1957.
25. Gronert K. Lipid autacoids in inflammation and injury responses: a matter of privilege. Mol. Interv. 2008, 8:28-35.
26. Gronert K., Hassan I.R. Reaping the benefits of renal protective lipid autacoids. Drug Discov. Today Dis. Mech. 2007, 4:3-10.
27. Gronert K., Virk S.M., Herman C.A. Thrombocytes are the predominant source of endogenous sulfidopeptide leukotrienes in the American bullfrog (Rana catesbeiana). Biochim. Biophys. Acta 1995, 1259:203-210.
28. 4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release. J. Exp. Med. 1998, 187:1285-1294.
29. Gronert K., Maheshwari N., Khan N., Hassan I.R., Dunn M., Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 2005, 280:15267-15278.
30. Hassan I.R., Gronert K. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 2009, 182:3223-3232.
31. Hollyfield J.G. Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the proctor lecture. Invest. Ophthalmol. Vis. Sci. 2010, 51:1275-1281.
32. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14:194-198.
33. Hollyfield J.G., Perez V.L., Salomon R.G. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol. Neurobiol. 2010, 41:290-298.
34. Hong S., Tjonahen E., Morgan E.L., Lu Y., Serhan C.N., Rowley A.F. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-mediator lipidomic analysis. Prostaglandins Other Lipid Mediat. 2005, 78:107-116.
35. Jin Y., Arita M., Zhang Q., Saban D.R., Chauhan S.K., Chiang N., Serhan C.N., Dana R. Novel anti-inflammatory and pro-resolving lipid mediators block inflammatory angiogenesis. Invest. Ophthalmol. Vis. Sci. 2009, 50:4743-4752.
36. Kaplan H.J., Streilein J.W. Immune response to immunization via the anterior chamber of the eye. I.F. lymphocyte-induced immune deviation. J. Immunol. 1977, 118:809-814.
37. Kaplan H.J., Streilein J.W., Stevens T.R. Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells. J. Immunol. 1975, 115:805-810.
38. Karim M.J., Bhattacherjee P., Biswas S., Paterson C.A. Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats. J. Ocul. Pharmacol. Ther. 2009, 25:483-486.
39. Kenchgowda S., Bazan H.E. Significance of lipid mediators in corneal injury and repair. J. Lipid. Res. 2009, 5:879-891.
40. Kennedy A.D., DeLeo F.R. Neutrophil apoptosis and the resolution of infection. Immunol. Res. 2009, 43:25-61.
41. Krishnamoorthy S., Recchiuti A., Chiang N., Yacoubian S., Lee C.H., Yang R., Petasis N.A., Serhan C.N. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:1660-1665.
42. Kuhn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 2006, 45:334-356.
43. Kumar V., Fausto N., Abbas A. Robbins and Cotran Pathological Basis of Disease 2004, W.B. Saunders Company, Philadelphia.
44. Lawrence T., Willoughby D.A., Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2002, 2:787-795.
45. Leedom A.J., Sullivan A.B., Dong B., Lau D., Gronert K. Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 2010, 176:74-84.
46. Levy B.D., Kohli P., Gotlinger K., Haworth O., Hong S., Kazani S., Israel E., Haley K.J., Serhan C.N. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 2007, 178:496-502.
47. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458.
48. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., Serhan C.N., Bazan N.G. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 2005, 115:2774-2783.
49. McDermott A.M., Perez V., Huang A.J., Pflugfelder S.C., Stern M.E., Baudouin C., Beuerman R.W., Burns A.R., Calder V.L., Calonge M., Chodosh J., Coster D.J., Dana R., Hazlett L.D., Jones D.B., Kim S.K., Knop E., Li D.Q., Mitchell B.M., Niederkorn J.Y., Pearlman E., Wilhelmus K.R., Kurie E. Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul. Surf. 2005, 3:S131-S138.
50. Medeiros R., Rodrigues G.B., Figueiredo C.P., Rodrigues E.B., Grumman A., Menezes-de-Lima O., Passos G.F., Calixto J.B. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis. Mol. Pharmacol. 2008, 74:154-161.
51. Miljanovic B., Trivedi K.A., Dana M.R., Gilbard J.P., Buring J.E., Schaumberg D.A. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am. J. Clin. Nutr. 2005, 82:887-893.
52. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
53. Nascimento-Silva V., Arruda M.A., Barja-Fidalgo C., Villela C.G., Fierro I.M. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am. J. Physiol. Cell. Physiol. 2005, 289:C557-C563.
54. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
55. Niederkorn J.Y. Regulatory T cells and the eye. Chem. Immunol. Allergy 2007, 92:131-139.
56. Niederkorn J.Y. Role of NKT cells in anterior chamber-associated immune deviation. Expert. Rev. Clin. Immunol. 2009, 5:137-144.
57. Niederkorn J.Y., Kaplan H.J. Rationale for immune response and the eye. Chem. Immunol. Allergy 2007, 92:1-3.
58. Niederkorn J.Y., Stein-Streilein J. History and physiology of immune privilege. Ocul. Immunol. Inflamm. 2010, 18:19-23.
59. Nozaki M., Raisler B.J., Sakurai E., Sarma J.V., Barnum S.R., Lambris J.D., Chen Y., Zhang K., Ambati B.K., Baffi J.Z., Ambati J. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2328-2333.
60. Ohta K., Kikuchi T., Arai S., Yoshida N., Sato A., Yoshimura N. Protective role of heme oxygenase-1 against endotoxin-induced uveitis in rats. Exp. Eye Res. 2003, 77:665-673.
61. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24:449-455.
62. Patil K., Bellner L., Cullaro G., Gotlinger K.H., Dunn M.W., Schwartzman M.L. Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest. Ophthalmol. Vis. Sci. 2008, 49:3379-3386.
63. Qin Q., Patil K.A., Gronert K., Sharma S.C. Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:201-207.
64. Raisler B.J., Nozaki M., Baffi J., Hauswirth W.W., Ambati J. Toward a higher fidelity model of AMD. Adv. Exp. Med. Biol. 2008, 613:185-192.
65. Rashid S., Jin Y., Ecoiffier T., Barabino S., Schaumberg D.A., Dana M.R. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch. Ophthalmol. 2008, 126:219-225.
66. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006, 86:583-650.
67. Sack R.A., Tan K.O., Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 1992, 33:626-640.
68. SanGiovanni J.P., Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 2005, 24:87-138.
69. SanGiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000, 105:1292-1298.
70. SanGiovanni J.P., Chew E.Y., Clemons T.E., Davis M.D., Ferris F.L., Gensler G.R., Kurinij N., Lindblad A.S., Milton R.C., Seddon J.M., Sperduto R.D. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS report no. 20. Arch. Ophthalmol. 2007, 125:671-679.
71. SanGiovanni J.P., Chew E.Y., Agron E., Clemons T.E., Ferris F.L., Gensler G., Lindblad A.S., Milton R.C., Seddon J.M., Klein R., Sperduto R.D. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch. Ophthalmol. 2008, 126:1274-1279.
72. SanGiovanni J.P., Agron E., Clemons T.E., Chew E.Y. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch. Ophthalmol. 2009, 127:110-112.
73. Sangiovanni J.P., Agron E., Meleth A.D., Reed G.F., Sperduto R.D., Clemons T.E., Chew E.Y. omega-3 long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the age-related eye disease study. Am. J. Clin. Nutr. 2009, 90:1601-1607.
74. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
75. Serhan C.N., Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 2005, 6:1191-1197.
76. Serhan C.N., Gotlinger K., Hong S., Lu Y., Siegelman J., Baer T., Yang R., Colgan S.P., Petasis N.A. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 2006, 176:1848-1859.
77. Serhan C.N., Brain S.D., Buckley C.D., Gilroy D.W., Haslett C., O'Neill L.A., Perretti M., Rossi A.G., Wallace J.L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007, 21:325-332.
78. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
79. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
80. Seta F., Bellner L., Rezzani R., Regan R.F., Dunn M.W., Abraham N.G., Gronert K., Laniado-Schwartzman M. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am. J. Pathol. 2006, 169:1612-1623.
81. Shureiqi I., Wu Y., Chen D., Yang X.L., Guan B., Morris J.S., Yang P., Newman R.A., Broaddus R., Hamilton S.R., Lynch P., Levin B., Fischer S.M., Lippman S.M. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 2005, 65:11486-11492.
82. Stein-Streilein J., Taylor A.W. An eye's view of T regulatory cells. J. Leukoc. Biol. 2007, 81:593-598.
83. Streilein J.W. Unraveling immune privilege. Science 1995, 270:1158-1159.
84. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 2003, 3:879-889.
85. Streilein J.W., Niederkorn J.Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 1981, 153:1058-1067.
86. Tuo J., Ross R.J., Herzlich A.A., Shen D., Ding X., Zhou M., Coon S.L., Hussein N., Salem N., Chan C.C. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am. J. Pathol. 2009, 175:799-807.
87. Vance R.E., Hong S., Gronert K., Serhan C.N., Mekalanos J.J. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2135-2139.
88. Willis D., Moore A.R., Willoughby D.A. Heme oxygenase isoform expression in cellular and antibody-mediated models of acute inflammation in the rat. J. Pathol. 2000, 190:627-634.
89. Willoughby D.A., Moore A.R., Colville-Nash P.R., Gilroy D. Resolution of inflammation. Int. J. Immunopharmacol. 2000, 22:1131-1135.
90. Wu Y., Fang B., Yang X.Q., Wang L., Chen D., Krasnykh V., Carter B.Z., Morris J.S., Shureiqi I. Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol. Ther. 2008, 16:886-892.
91. Zhang C., Bazan N.G. Lipid-mediated cell signaling protects against injury and neurodegeneration. J. Nutr. 2010, 140:858-863.